Global Breast Lesion Localization Market Revenues To Grow At Nearly 4.4% from 2022-2031 – Hologic, Inc, Becton, Dickinson and Company, Merit Medical Systems

The global breast lesion localization market size was USD 254 million in 2021 and it is anticipated to reach USD 390.6 million in 2031, growing at a rate of 4.4% from 2022-2031.

Breast lesion localization is a medical device used in the detection of malignant and nonmalignant tumors. It is used in the preoperative marketing of nonpalatable breast lesions. There are different types f breast lesion localization devices developed using different techniques: radiations, wires, radar, and electromagnetic. Breast lesion localization methods are used to detect the abnormalities in terms of a lump or tumor in the breasts.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample –

There are various types of breast lesion localization methods used across the globe to detect a lump or tumor in the breasts. However, the rapid increase in the number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for the growth of the breast lesion localization market.

Market Trends and Drivers

The major factor boosting the growth of the market is the increasing incidence of breast cancer. Breast cancer is among the most common diseases affecting women in developed and developing countries. As per the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women globally. Worldwide, there has been significant growth in the number of breast cancer cases. This can majorly be attributed to changing lifestyles, the increasing use of oral contraceptives, and the rising number of women undergoing cosmetic surgeries, such as breast enhancement.

Get A Customized Scope to Match, Your Need Ask an Expert-

Similarly, the growing rate of the aging population is also boosting the growth of the market. With age, the risk of developing breast cancer increases. Aging increases multipotent progenitors and decreases the number of myoepithelial cells, which line the breast’s milk-producing luminal cells and serve as tumor suppressors. As per the American Cancer Society, approximately 1 out of 8 invasive breast cancers develop in women less than 45 years. Conversely, approximately 2 out of 3 invasive breast cancers develop in women aged 55 and above.

For In-Depth Competitive Analysis, Purchase this Report –

Market Segments

By Type

  • Wire Localization
  • Radioisotope Localization
  • Radio-guided Occult Lesion Localization
  • Radioactive Seed Localization
  • Magnetic Localization
  • Electromagnetic Localization
  • Other Localization Methods

By Usage

  • Breast Biopsy
  • Breast Conservation (Lumpectomy)

Major Players of the Global Breast Lesion Localization Market

The global breast lesion localization market report includes players such as Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US), Laurane Medical LLC (France), Endomagnetics Ltd. (UK), Intramedical Imaging, LLC (US), Isoaid (US), Surgiceye GmbH (Germany), Ranfac Corp. (US), Mermaid Medical Group (Denmark), Izi Medical Products, LLC (US), Matek Medikal (Turkey), Tsunami Medical Srl (Italy), BPB Medica (Italy), Sirius Medical Systems B.V. (Netherlands), Molli Surgical Inc. (Canada), Sterylab S.R.L. (Italy), CP Medical (Georgia), MDL SRL (Italy), Biomedical Srl (Italy), Elucent Medical (US), Vigeo srl (Italy), and Medax Medical Devices (Italy).

New Report Published by Global Insight Services:

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700